• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 microRNAs 作为慢性心力衰竭加速性肌少症的生物标志物。

Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure.

机构信息

Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, AE.

University of Health Sciences, Lahore, PK.

出版信息

Glob Heart. 2021 Aug 30;16(1):56. doi: 10.5334/gh.943. eCollection 2021.

DOI:10.5334/gh.943
PMID:34692380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8415175/
Abstract

BACKGROUND

Sarcopenia is a critical finding in patients with chronic heart failure (CHF). However, the search for a definitive biomarker to predict muscle and functional decline in CHF remains elusive.

OBJECTIVES

We aimed to correlate the circulating levels of selected miRs with the indexes of sarcopenia during healthy aging and in patients with CHF.

METHODS

We analyzed the association of circulating microRNAs (miRs) levels including miR-21, miR-434-3p, miR424-5p, miR-133a, miR-455-3p and miR-181a with sarcopenia indexes in male, 61-73 years old healthy controls and patients with CHF (N = 89-92/group).

RESULTS

Patients with CHF had lower hand-grip strength (HGS), appendicular skeletal mass index (ASMI) and physical capacity than healthy controls. Circulating miR-21 levels were higher and miR-181a, miR-133a, miR-434-3p and miR-455-3p levels were lower in patients with CHF than healthy controls. Among the sarcopenia indexes, HGS showed the strongest correlation with miR-133a while ASMI showed the strongest correlations with miR-133a, miR-434-3p and miR-455-3p. Among the miRs, miR-434-3p showed the highest area under the curve in testing for sensitivity and specificity for CHF. These changes were associated with higher expressions of the markers of inflammation, oxidative stress and muscle damage in CHF patients.

CONCLUSION

Taken together, our data show that circulating miRs can be useful markers of muscle health and physical capacity in the sarcopenic elderly with CHF.

摘要

背景

肌肉减少症是慢性心力衰竭(CHF)患者的一个重要发现。然而,寻找一种明确的生物标志物来预测 CHF 中的肌肉和功能下降仍然难以捉摸。

目的

我们旨在研究选定的 miRs 循环水平与健康老年人和 CHF 患者的肌肉减少症指标之间的相关性。

方法

我们分析了包括 miR-21、miR-434-3p、miR424-5p、miR-133a、miR-455-3p 和 miR-181a 在内的循环 microRNAs (miRs) 水平与男性 61-73 岁健康对照组和 CHF 患者(每组 89-92 例)肌肉减少症指标的相关性。

结果

与健康对照组相比,CHF 患者的握力(HGS)、四肢骨骼肌质量指数(ASMI)和体力较差。CHF 患者的循环 miR-21 水平较高,miR-181a、miR-133a、miR-434-3p 和 miR-455-3p 水平较低。在肌肉减少症指标中,HGS 与 miR-133a 相关性最强,而 ASMI 与 miR-133a、miR-434-3p 和 miR-455-3p 相关性最强。在这些 miR 中,miR-434-3p 在检测 CHF 的敏感性和特异性方面表现出最高的曲线下面积。这些变化与 CHF 患者炎症、氧化应激和肌肉损伤标志物的高表达有关。

结论

综上所述,我们的数据表明,循环 miRs 可作为 CHF 伴肌肉减少症老年患者肌肉健康和体力的有用标志物。

相似文献

1
Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure.循环 microRNAs 作为慢性心力衰竭加速性肌少症的生物标志物。
Glob Heart. 2021 Aug 30;16(1):56. doi: 10.5334/gh.943. eCollection 2021.
2
Circulating miRNA-1-3p as Biomarker of Accelerated Sarcopenia in Patients Diagnosed with Chronic Heart Failure.循环 miRNA-1-3p 作为诊断为慢性心力衰竭患者的加速性骨骼肌减少症的生物标志物。
Rev Invest Clin. 2022;74(5):276-268. doi: 10.24875/RIC.22000151.
3
Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases.呼吸系统疾病中肌肉减少症加速的循环生物标志物
Biology (Basel). 2020 Oct 3;9(10):322. doi: 10.3390/biology9100322.
4
Bone and muscle specific circulating microRNAs in postmenopausal women based on osteoporosis and sarcopenia status.基于骨质疏松症和肌肉减少症状况的绝经后妇女的骨和肌肉特异性循环 microRNAs。
Bone. 2019 Mar;120:271-278. doi: 10.1016/j.bone.2018.11.001. Epub 2018 Nov 5.
5
Clinical Value of Circulating ZFAS1 and miR-590-3p in the Diagnosis and Prognosis of Chronic Heart Failure.循环 ZFAS1 和 miR-590-3p 在慢性心力衰竭诊断和预后中的临床价值。
Cardiovasc Toxicol. 2021 Nov;21(11):880-888. doi: 10.1007/s12012-021-09678-7. Epub 2021 Jul 28.
6
Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults.循环 microRNA-486 和 microRNA-146a 可作为老年人肌少症的潜在生物标志物。
BMC Geriatr. 2021 Jan 30;21(1):86. doi: 10.1186/s12877-021-02040-0.
7
Increasing Fracture Risk Associates With Plasma Circulating MicroRNAs in Aging People's Sarcopenia.骨折风险增加与老年人肌肉减少症中的血浆循环微小RNA相关。
Front Physiol. 2021 Jun 7;12:678610. doi: 10.3389/fphys.2021.678610. eCollection 2021.
8
Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta-analysis.microRNAs 在检测射血分数降低或保留的心力衰竭中的诊断性能:系统评价和荟萃分析。
Eur J Heart Fail. 2022 Dec;24(12):2212-2225. doi: 10.1002/ejhf.2700. Epub 2022 Oct 27.
9
Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure.循环 miR-19b-3p 作为急性心力衰竭的新型预后生物标志物。
J Am Heart Assoc. 2021 Oct 19;10(20):e022304. doi: 10.1161/JAHA.121.022304. Epub 2021 Oct 6.
10
Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.循环 microRNAs 在外周血中的水平与体外受精过程中的反复流产和胚胎移植结局的关系。
J Transl Med. 2018 Jul 4;16(1):186. doi: 10.1186/s12967-018-1556-x.

引用本文的文献

1
From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure.从利钠肽到微小RNA:心力衰竭中的多分析物液体活检前景
Biomolecules. 2025 Aug 19;15(8):1189. doi: 10.3390/biom15081189.
2
Sarcopenia in chronic obstructive pulmonary disease: mechanisms, diagnosis, and management strategies.慢性阻塞性肺疾病中的肌肉减少症:机制、诊断及管理策略
Ann Med Surg (Lond). 2025 Jul 16;87(8):5106-5121. doi: 10.1097/MS9.0000000000003584. eCollection 2025 Aug.
3
Molecular constraints of sarcopenia in the ageing muscle.

本文引用的文献

1
Prediction of sarcopenia using a battery of circulating biomarkers.利用一系列循环生物标志物预测肌肉减少症。
Sci Rep. 2021 Apr 21;11(1):8632. doi: 10.1038/s41598-021-87974-6.
2
Reduced sarcoplasmic reticulum Ca ATPase activity underlies skeletal muscle wasting in asthma.肌浆网钙ATP酶活性降低是哮喘患者骨骼肌萎缩的基础。
Life Sci. 2021 May 15;273:119296. doi: 10.1016/j.lfs.2021.119296. Epub 2021 Mar 3.
3
Restoration of Sarcoplasmic Reticulum Ca ATPase (SERCA) Activity Prevents Age-Related Muscle Atrophy and Weakness in Mice.
衰老肌肉中肌肉减少症的分子限制因素
Front Aging. 2025 Jul 3;6:1588014. doi: 10.3389/fragi.2025.1588014. eCollection 2025.
4
Role of microRNAs in Osteosarcopenic Obesity/Adiposity: A Scoping Review.微小RNA在骨质疏松性肥胖/脂肪过多症中的作用:一项范围综述
Cells. 2025 May 29;14(11):802. doi: 10.3390/cells14110802.
5
Towards Precision in Sarcopenia Assessment: The Challenges of Multimodal Data Analysis in the Era of AI.迈向肌肉减少症评估的精准化:人工智能时代多模态数据分析的挑战
Int J Mol Sci. 2025 May 7;26(9):4428. doi: 10.3390/ijms26094428.
6
Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases.阿尔茨海默病患者血浆神经丝轻链与肌肉减少症及身体机能的关联
Acta Neurol Belg. 2025 Mar 11. doi: 10.1007/s13760-025-02759-2.
7
Molecular mechanisms and therapeutic strategies of gut microbiota modulation in Sarcopenia (Review).肌肉减少症中肠道微生物群调节的分子机制和治疗策略(综述)
Oncol Lett. 2024 Dec 17;29(3):104. doi: 10.3892/ol.2024.14850. eCollection 2025 Mar.
8
The Pathology of Intestinal Mucosal Disruption; Implications for Muscle Loss and Physical Dependency from Late Adolescence to Octogenarians.肠道黏膜破坏的病理学;对从青少年晚期到八旬老人肌肉流失和身体依赖的影响。
Int J Gen Med. 2024 Dec 12;17:6117-6126. doi: 10.2147/IJGM.S501358. eCollection 2024.
9
Melatonin protects against sarcopenia in middle-aged mice.褪黑素可预防中年小鼠的肌肉减少症。
Histol Histopathol. 2025 May;40(5):745-755. doi: 10.14670/HH-18-814. Epub 2024 Sep 13.
10
Metformin effects on plasma zonulin levels correlate with enhanced physical performance in osteoarthritis patients with diabetes.二甲双胍对血浆亲环素水平的影响与糖尿病性骨关节炎患者体能的改善相关。
Inflammopharmacology. 2024 Oct;32(5):3195-3203. doi: 10.1007/s10787-024-01558-0. Epub 2024 Aug 19.
肌浆网 Ca2+-ATP 酶(SERCA)活性的恢复可预防小鼠与年龄相关的肌肉萎缩和无力。
Int J Mol Sci. 2020 Dec 22;22(1):37. doi: 10.3390/ijms22010037.
4
Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases.呼吸系统疾病中肌肉减少症加速的循环生物标志物
Biology (Basel). 2020 Oct 3;9(10):322. doi: 10.3390/biology9100322.
5
Plasma CAF22 Levels as a Useful Predictor of Muscle Health in Patients with Chronic Obstructive Pulmonary Disease.血浆CAF22水平作为慢性阻塞性肺疾病患者肌肉健康的有用预测指标
Biology (Basel). 2020 Jul 15;9(7):166. doi: 10.3390/biology9070166.
6
MicroRNAs in Sarcopenia: A Systematic Review.肌肉减少症中的微小RNA:一项系统综述。
Front Med (Lausanne). 2020 May 28;7:180. doi: 10.3389/fmed.2020.00180. eCollection 2020.
7
Circulating MicroRNAs in Plasma Decrease in Response to Sarcopenia in the Elderly.老年人血浆中循环微RNA水平随肌肉减少症而降低。
Front Genet. 2020 Mar 5;11:167. doi: 10.3389/fgene.2020.00167. eCollection 2020.
8
Circulating Biomarkers of Handgrip Strength and Lung Function in Chronic Obstructive Pulmonary Disease.手握力和肺功能的循环生物标志物与慢性阻塞性肺疾病。
Int J Chron Obstruct Pulmon Dis. 2020 Feb 11;15:311-321. doi: 10.2147/COPD.S225765. eCollection 2020.
9
New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure.慢性心力衰竭中肌肉减少症发病机制和治疗的新见解。
Theranostics. 2019 May 31;9(14):4019-4029. doi: 10.7150/thno.33000. eCollection 2019.
10
The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men.肌肉功能、肌肉质量和肌肉减少症对瑞典高龄男性独立衰老的影响。
BMC Geriatr. 2019 May 29;19(1):153. doi: 10.1186/s12877-019-1142-y.